News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
LEE KENNETH B JR
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2021 |
4
| LEE KENNETH B JR (Director) has filed a Form 4 on EYENOVIA, INC.|
Txns:
| Granted 6,963 shares
@ $0
Granted 9,653 options to buy
@ $3.59, valued at
$34.7k
|
|
| 09/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2020 |
4
| LEE KENNETH B JR (Director) has filed a Form 4 on EYENOVIA, INC.|
Txns:
| Granted 7,288 shares
@ $0
Granted 9,820 options to buy
@ $3.43, valued at
$33.7k
|
|
| 05/14/2020 |
4
| LEE KENNETH B JR (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 40,000 options to buy
@ $5.41, valued at
$216.4k
|
|
| 11/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2019 |
4
| LEE KENNETH B JR (Director) has filed a Form 4 on EYENOVIA, INC.|
Txns:
| Granted 8,038 shares
@ $0
Granted 9,057 options to buy
@ $3.11, valued at
$28.2k
|
|
| 05/31/2019 |
4
| LEE KENNETH B JR (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $2.91, valued at
$87.3k
|
|
| 10/24/2018 |
4
| Hatteras Venture Advisors III, LLC (10% Owner) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Converted 52,690 shares
@ $0
Converted 1,683,420 shares
@ $0
Bought 137,513 shares
@ $5, valued at
$687.6k
Converted 150,612 shares
@ $0
Bought 12,487 shares
@ $5, valued at
$62.4k
Converted 4,846 shares
@ $0
Converted 266,481 shares
@ $0
Bought 150,000 shares
@ $5, valued at
$750k
Exercised (in-or-at-the-money) 19,061 options to buy
@ $0.12, valued at
$2.3k
Exercised (in-or-at-the-money) 19,061 preferred shares
@ $0.12, valued at
$2.3k
Sold 458 preferred shares
@ $5, valued at
$2.3k
|
|
| 10/17/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/26/2018 |
4
| LEE KENNETH B JR (Director) has filed a Form 4 on EYENOVIA, INC.|
Txns:
| Granted 4,033 shares
@ $0
Granted 4,465 options to buy
@ $6.2, valued at
$27.7k
|
|
| 06/22/2018 |
4
| LEE KENNETH B JR (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $6.09, valued at
$182.7k
|
|
| 06/01/2018 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 758,290 shares
@ $48, valued at
$36.4M
Sold 41,710 shares
@ $48, valued at
$2M
|
|
| 05/23/2018 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 29,005 shares
@ $51.1604, valued at
$1.5M
Sold 1,595 shares
@ $51.0589, valued at
$81.4k
Sold 474 shares
@ $52.13, valued at
$24.7k
Sold 26 shares
@ $52.13, valued at
$1.4k
Sold 5,592 shares
@ $50.8593, valued at
$284.4k
Sold 308 shares
@ $50.6851, valued at
$15.6k
Sold 474 shares
@ $50.5, valued at
$23.9k
Sold 26 shares
@ $50.5, valued at
$1.3k
|
|
| 04/05/2018 |
3
| LEE KENNETH B JR (Director) has filed a Form 3 on EYENOVIA, INC. |
| 12/04/2017 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Disposed of 99,513 shares
@ $0
Acquired 995 shares
@ $0 |
|
| 05/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/12/2017 |
4
| LEE KENNETH B JR (Director) has filed a Form 4 on Aralez Pharmaceuticals Inc. |
| 03/17/2017 |
4
| LEE KENNETH B JR (Director) has filed a Form 4 on Aralez Pharmaceuticals Inc. |
| 01/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/15/2016 |
4
| LEE KENNETH B JR (Director) has filed a Form 4 on Aralez Pharmaceuticals Inc. |
| 06/20/2016 |
4
| LEE KENNETH B JR (Director) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Granted 7,500 shares
@ $0
Granted 15,000 options to buy
@ $3.42, valued at
$51.3k
|
|
| 06/14/2016 |
4
| LEE KENNETH B JR (Director) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Paid exercise price by delivering 1,404 shares
@ $3.58, valued at
$5k
|
|
| 06/07/2016 |
4
| Hatteras Venture Advisors III, LLC (10% Owner) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Converted 1,598,219 shares
@ $0
Sold 69 shares
@ $7, valued at
$483
Bought 107,142 shares
@ $7, valued at
$750k
Converted 2,035,907 preferred shares
@ $0
Converted 689,388 preferred shares
@ $0
Converted 432,940 preferred shares
@ $0
Converted 337,898 preferred shares
@ $0
Exercised (in-or-at-the-money) 19,900 options to buy
@ $0.022, valued at
$437.8
Exercised (in-or-at-the-money) 1,805 options to buy
@ $0.022, valued at
$39.7 |
|
| 06/07/2016 |
4
| Hatteras Venture Advisors IV SBIC, LLC (10% Owner) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Converted 1,598,223 shares
@ $0
Sold 69 shares
@ $7, valued at
$483
Bought 414,286 shares
@ $7, valued at
$2.9M
Converted 2,035,908 preferred shares
@ $0
Converted 689,388 preferred shares
@ $0
Converted 432,941 preferred shares
@ $0
Converted 337,897 preferred shares
@ $0
Exercised (in-or-at-the-money) 21,705 options to buy
@ $0.022, valued at
$477.5 |
|
| 06/01/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/01/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|
|